ACTRN12611000460909
Completed
Phase 1
Investigation into the effect of micronutrients on stress and anxiety post-earthquake: Comparison of two micronutrient formulas
niversity of Canterbury0 sites100 target enrollmentMay 4, 2011
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Stress and anxiety resulting from the Christchurch earthquakes
- Sponsor
- niversity of Canterbury
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants must have been in Christchurch at the time of at least one of the major earthquakes (September 4th 2010 or February 22nd 2011\). They must be free of psychotropic medications for the trial. Further, they must be over 18 years of age, possess a level of understanding sufficient to complete the questionnaires and examinations required by the protocol and be considered reliable and compliant with the protocol (including the ingestion of as many as 8 capsules/day), and must be able to eat at least a snack twice per day. They must also have at least one score above the cutoffs of the Depression, Anxiety and Stress Scale: Cutoffs have been provided to indicate mild, moderate or severe problems; anything below 13 (for depression), 10 (for anxiety) and 18 (for stress) is considered within the normal to mild range.
Exclusion Criteria
- •Participants will be excluded from the study for any of the following reasons:
- •1\.Neurological disorder involving brain or other central function (e.g., epilepsy, MS, narcolepsy). Purely peripheral neurological problems are not excluded (e.g., Raynaud’s, peripheral diabetic neuropathy).
- •2\.Any serious medical condition for which major medical interventions are anticipated during the duration of the trial.
- •3\.Any participant known to be allergic to the ingredients of the intervention (including ginkgo biloba, germanium sesquioxide, or grape seed) will be excluded.
- •4\.Pregnant or breastfeeding.
- •5\.Evidence of untreated or unstable thyroid disease (based on interview)
- •6\.Any known abnormality of mineral metabolism (e.g., Wilson’s disease, haemochromatosis).
- •7\.Any other medication with primarily central nervous system activity, including mood stabilizers. Participants must have been off of these medications for a minimum of four weeks prior to the trial.
- •8\.Participants will be excluded temporarily if they have taken an oral antibiotic in the previous 6 weeks.
- •9\.Any type of nutritional or herbal supplement, known to have a centrally\-acting effect, will result in a participant's exclusion. However, participants who have been taking supplements such as echinacea, chondroitin, or glucosamine may enter the study if a) they have been taking these agents for at least one month prior to the study, and b) they continue on these agents throughout the study. We will permit people to take as much as 1 g/day of EPA and DHA combined.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A pilot study investigating the impact of micronutrients on children with Attention-Deficit/Hyperactivity Disorder (ADHD)ACTRN12612000645853Department of Psychology, University of Canterbury15
Withdrawn
Phase 4
Investigation into the effect of micronutrients on stress and anxiety following the Christchurch Mosque shootingsACTRN12619000759190Julia Rucklidge50
Completed
Not Applicable
Investigating the effects of a micronutrient formula on insomnia in teachersInsomniaMental Health - Other mental health disordersACTRN12616001026415niversity of Canterbury15
Completed
Not Applicable
sing Micronutrients in Smoking Cessation Treatment: A Double-Blind Randomized Placebo-controlled trial.icotine addictionNicotine addictionAlternative and Complementary Medicine - Other alternative and complementary medicineMental Health - AddictionACTRN12615000201572niversity of Canterbury80
Completed
Not Applicable
Investigation into the effect of a micronutrient formula on symptoms of insomniaInsomniaMental Health - Other mental health disordersACTRN12613000364774niversity of Canterbury15